CRYOPORT, INC. Share-based Payment Arrangement, Accelerated Cost
CRYOPORT, INC. (CYRX) reported Share-based Payment Arrangement, Accelerated Cost of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2022-02-28
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for the quarter ending 2019-12-31 was $1.23M.
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for the quarter ending 2019-09-30 was $1.23M.
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for the quarter ending 2018-12-31 was $0.00.
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for fiscal 2019 was $9.56M.
- CRYOPORT, INC. share-based payment arrangement, accelerated cost for fiscal 2018 was $0.00.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 3 month as first filed | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month | Share-based Payment Arrangement, Accelerated Cost 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 | |||||
| 2019-12-31 | $1.23M 10-K · filed 2021-03-01 | $2.46M derived: sum of 2 quarters · filed 2022-02-28 | $9.56M 10-K · filed 2022-02-28 | $9.56M 10-K · filed 2020-03-10 | ||
| 2019-09-30 | $1.23M 10-K · filed 2022-02-28 | $10.80M 10-Q · filed 2019-11-12 | $10.79M 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |